ArticleDrug design, development and therapy2026
Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients with Metastatic Soft Tissue Sarcoma Following TKI Treatment Failure: A Retrospective Study.
Guohui Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.